
Enalapril Maleate is a potent, long-acting ACE inhibitor used in cardiovascular research to study the regulation of the renin-angiotensin-aldosterone system (RAAS) and blood pressure management.
In the field of vascular biology and nephrology, the ability to suppress the renin-angiotensin-aldosterone system (RAAS) is a major advantage. Enalapril Maleate is specifically selected because it decreases peripheral arterial resistance without significantly increasing heart rate. For instance, it is used to investigate the physiological management of congestive heart failure and diabetic nephropathy. Consequently, it facilitates the development of high-efficacy oral tablets and liquid formulations with higher efficiency. As a result, Zyntex ensures that our high-purity API maintains strict polymorphic consistency and meets global pharmacopoeial standards for organic impurities.
Moreover, the research-grade Enalapril Maleate provided by Zyntex is a vital component in the study of bradykinin degradation and its effects on vasodilation. This application allows for the creation of advanced profiles for cardiac remodeling prevention, undoubtedly pushing the boundaries of what is possible in modern cardiovascular therapy. At the same time, its role in improving glomerular filtration hemodynamics is highly valued by global clinical research organizations. In short, our product serves as a dependable “precision-inhibitor” for companies focusing on both heart health and sustainable healthcare infrastructure.
Recently, scientific interest has surged regarding the use of Enalapril in studies involving the prevention of kidney damage in hypertensive patients. Because of this, Zyntex offers specialized analytical documentation to provide safer and more convenient validation in various laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous logistical safety. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in fine chemistry or clinical research—achieve the highest levels of purity and yield.
This high-performance cardiovascular agent is specifically vital in the following four sectors:
A potent agent for studying ventricular hypertrophy; thus enabling the production of high-value cardiac imaging data.
Key API for first-line antihypertensive medications; consequently vital for developing stable clinical formulations.
Used to investigate renal protective effects; undoubtedly essential for identifying new pathways in chronic kidney disease.
Used to monitor the impact of ACE inhibitors on insulin sensitivity; specifically helping researchers study metabolic syndrome links.
| Parameter | Standard Value |
|---|---|
| Product Name | Enalapril Maleate |
| Assay / Purity | 98.0% – 102.0% (Dried Basis) |
| Molecular Formula | C20H28N2O5 · C4H4O4 |
| CAS Number | 76095-16-4 |
⚠️ Safety Warning: Enalapril Maleate is a potent vasodilator. Therefore, it must be handled under professional laboratory supervision using appropriate PPE. Avoid inhalation of dust. Store in a cool, dry place and protect from light to prevent potential chemical degradation of the maleate salt form.
For comprehensive toxicological profiles, material safety data sheets (MSDS), and physical property validation, please refer to the official PubChem entry: Chemical Safety Data – Enalapril Maleate (76095-16-4)